Calamos Advisors’s Bruker Corporation 6.375% Series A Preferred Stock BRKRP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$45M Sell
100,560
-41,401
-29% -$14.9M 0.15% 143
2026
Q1
$40.1M Buy
141,961
+343
+0.2% +$112K 0.14% 172
2025
Q4
$51.8M Buy
141,618
+41,411
+41% +$14M 0.19% 121
2025
Q3
$27.2M Buy
+100,207
New +$26.8M 0.1% 221

Other funds holding BRKRP

Calamos Advisors's BRKRP Position: Q2 2026 in Review

Calamos Advisors reduced its Bruker Corporation 6.375% Series A Preferred Stock (BRKRP) stake by 29% in Q2 2026, selling an estimated $14.9M and leaving 100,560 shares worth $45M. The position accounts for 0.15% of the portfolio, ranked #143.

Calamos Advisors first reported a position in BRKRP in Q3 2025 and has held it in 4 quarters since. The position peaked at $51.8M in Q4 2025. 5 funds tracked by Wall St. Rank hold BRKRP as of Q2 2026.

  • Calamos Advisors held 100,560 shares of Bruker Corporation 6.375% Series A Preferred Stock worth $45M as of Q2 2026.
  • Calamos Advisors sold 41,401 Bruker Corporation 6.375% Series A Preferred Stock shares in Q2 2026, an estimated $14.9M.
  • Bruker Corporation 6.375% Series A Preferred Stock made up 0.15% of Calamos Advisors's portfolio in Q2 2026, its #143 holding.
  • Calamos Advisors first reported a position in Bruker Corporation 6.375% Series A Preferred Stock in Q3 2025 and has held it in 4 quarters since.
  • Calamos Advisors's Bruker Corporation 6.375% Series A Preferred Stock position peaked at $51.8M in Q4 2025.
  • 5 funds tracked by Wall St. Rank held Bruker Corporation 6.375% Series A Preferred Stock as of Q2 2026.

Based on Calamos Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.